TIDES Europe: Oligonucleotide and Peptide Therapeutics

Conference Details

Date: 11 November 2025

Time: To be announced

Duration: 3 days

Location: Basel, Switzerland

Cost: £ 1049 - £ 3699

Organiser: Informa Connect

Conference Website

Conference Description

Cross-Pollinates Expertise Across Oligonucleotides, Peptides, mRNA, Genome Editing and Drug Delivery

Cross-fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas.

The TIDES Europe conference agenda features scientific tracks covering in-depth discovery, development and manufacturing strategies, trends and technologies across the entire oligonucleotide and peptide spectrum and areas of focus below.

Oligonucleotide Chemistry, Manufacturing & Controls

Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.

Oligonucleotide Discovery, Preclinical and Clinical

Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Peptide Chemistry, Manufacturing & Controls

Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.

Peptide Discovery, Preclinical and Clinical

Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

mRNA Therapeutics and Genome Editing

Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies.

Macromolecular Drug Delivery

Learn about the latest technologies and approaches to overcome the delivery challenges of oligonucleotides, peptides, mRNA and other macromolecules and discover new delivery strategies for genome editing.